Isocitrate Dehydrogenase Gene Mutation clinical trials at UC Cancer

1 research study open to eligible people

A Study of HMPL-306 in Advanced Hematological Malignancies With mIDH
open to eligible people ages 18 years and up
An open label single-arm clinical trial to evaluate the safety, tolerability, PK, PD, and preliminary efficacy of HMPL-306 in subjects with advanced relapsed, refractory, or resistant hematological malignancies that harbor IDH mutations.
at UC Irvine

Last updated: May 5, 2023